Manufacturer
Hetero Labs
Contents
Telmisartan
Indication
Essential HTN. Reduce risk of MI, stroke or death in patients ≥55 yr at high risk of developing major CV events who are unable to take ACE inhibitors.
Instruction
May be taken with or without food.
Drug interaction
Increased digoxin peak plasma & trough conc. Increased risk of hyperkalaemia w/ K-containing salt substitutes, K-sparing diuretics, K supplements, ACE inhibitors, AIIA, NSAIDs, selective COX-2 inhibitors, heparin, immunosuppressives, trimethoprim. Reversible increased serum lithium conc & toxicity. Reduced antihypertensive effect w/ NSAIDs ie, acetylsalicylic acid, COX-2 inhibitors, non-selective NSAIDs. Increased risk of vol depletion & hypotension w/ high-dose diuretics eg, furosemide or hydrochlorothiazide. Increased BP-lowering effect w/ other antihypertensives. Potentiated hypotensive effects w/ baclofen, amifostine. Aggravated orthostatic hypotension w/ alcohol, barbiturates, narcotics or antidepressants.
Malaysia
